164 related articles for article (PubMed ID: 8737372)
1. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.
DaSilva L; Rui H; Erwin RA; Howard OM; Kirken RA; Malabarba MG; Hackett RH; Larner AC; Farrar WL
Mol Cell Endocrinol; 1996 Mar; 117(2):131-40. PubMed ID: 8737372
[TBL] [Abstract][Full Text] [Related]
2. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
3. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
Han Y; Watling D; Rogers NC; Stark GR
Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
[TBL] [Abstract][Full Text] [Related]
4. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
5. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
Pezet A; Ferrag F; Kelly PA; Edery M
J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
[TBL] [Abstract][Full Text] [Related]
7. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
8. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter.
Wang Y; O'Neal KD; Yu-Lee L
Mol Endocrinol; 1997 Aug; 11(9):1353-64. PubMed ID: 9259325
[TBL] [Abstract][Full Text] [Related]
9. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
Ali S; Ali S
J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
Russell DL; Richards JS
Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
[TBL] [Abstract][Full Text] [Related]
11. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
[TBL] [Abstract][Full Text] [Related]
12. Selective coupling of STAT factors to the mouse prolactin receptor.
Mayr S; Welte T; Windegger M; Lechner J; May P; Heinrich PC; Horn F; Doppler W
Eur J Biochem; 1998 Dec; 258(2):784-93. PubMed ID: 9874248
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
Rui H; Xu J; Mehta S; Fang H; Williams J; Dong F; Grimley PM
J Biol Chem; 1998 Jan; 273(1):28-32. PubMed ID: 9417042
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells.
Pallard C; Gouilleux F; Charon M; Groner B; Gisselbrecht S; Dusanter-Fourt I
J Biol Chem; 1995 Jul; 270(27):15942-5. PubMed ID: 7608147
[TBL] [Abstract][Full Text] [Related]
15. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
[TBL] [Abstract][Full Text] [Related]
17. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
19. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
Pezet A; Buteau H; Kelly PA; Edery M
Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
[TBL] [Abstract][Full Text] [Related]
20. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
Selvaraj NG; Omi E; Gibori G; Rao MC
Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
